Dr David Brough was recently named the Bionow Promising Technologist of the year at the 14th annual Bionow Awards.
Bionow is an organisation that helps support business growth and innovation in the biomedical and life science sector. The award ceremony highlights the best technologies and individuals that are present in the north of the UK.
David was recognised for developing and driving the translation of his research findings of a new class of potential therapeutic drugs. The drugs specifically targeted a molecule called NLRP3 and could help with central nervous system inflammation and Alzheimer’s disease. His work has led to a recently patented class of compounds that enables specific control of damaging inflammatory reactions.
“I was delighted to accept this award on behalf of our team in the brain inflammation group and in the School of Pharmacy. We now know that the process of inflammation contributes to the worsening of neurodegenerative disease. Our goal is to understand the biology of inflammation, and through improved understanding, develop new ways to target disease causing mechanisms.”
On the awards as a whole, Dr Geoff Davison, Chief Executive Officer of Bionow, commented:
“The 14th Annual Bionow Awards Dinner has been our best yet and we would like to congratulate all of the award winners and thank the sponsors for their continued support. We were delighted to spend the evening celebrating the achievements in our sector which showcases the strength and breadth of the sector in the North and demonstrating how we can contribute to the Northern Powerhouse.”